Vitrakvi
Tumour-agnostic drugs ‘game-changing’, says NICE as it rejects one from Bayer
Phil Taylor
Bayer, Oncology, rare cancer, Roche, Rozlytrek, Vitrakvi
0 Comment
X
Tumour-agnostic drugs ‘game-changing’, says NICE as it rejects one from Bayer
https://pharmaphorum.com/news/tumour-agnostic-drugs-game-changing-says-nice-as-it-rejects-one-from-bayer/
Bayer’s Vitrakvi is first tumour-agnostic drug approved in EU
Phil Taylor
Bayer, Oncology, Roche, Rozlytrek, Vitrakvi
0 Comment
X
Bayer’s Vitrakvi is first tumour-agnostic drug approved in EU
https://pharmaphorum.com/news/bayers-vitrakvi-is-first-tumour-agnostic-drug-approved-in-eu/